QLOSI Drug Patent Profile
✉ Email this page to a colleague
When do Qlosi patents expire, and what generic alternatives are available?
Qlosi is a drug marketed by Orasis Pharms and is included in one NDA. There are three patents protecting this drug.
This drug has twenty-four patent family members in fourteen countries.
The generic ingredient in QLOSI is pilocarpine hydrochloride. There are twelve drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the pilocarpine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Qlosi
A generic version of QLOSI was approved as pilocarpine hydrochloride by PADAGIS US on November 16th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for QLOSI?
- What are the global sales for QLOSI?
- What is Average Wholesale Price for QLOSI?
Summary for QLOSI
International Patents: | 24 |
US Patents: | 3 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | QLOSI at DailyMed |
US Patents and Regulatory Information for QLOSI
QLOSI is protected by three US patents and one FDA Regulatory Exclusivity.
Patents protecting QLOSI
Ophthalmic pharmaceutical compositions and uses relating thereto
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA
Ophthalmic pharmaceutical compositions and uses relating thereto
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA
Ophthalmic pharmaceutical compositions and uses relating thereto
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PRESBYOPIA
FDA Regulatory Exclusivity protecting QLOSI
NEW PRODUCT
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Orasis Pharms | QLOSI | pilocarpine hydrochloride | SOLUTION;OPHTHALMIC | 217836-001 | Oct 17, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for QLOSI
See the table below for patents covering QLOSI around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 3500255 | COMPOSITIONS PHARMACEUTIQUES OPHTALMIQUES ET UTILISATIONS ASSOCIÉES (OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO) | ⤷ Sign Up |
South Korea | 20220162876 | 안과용 약학 조성물 및 이와 관련된 용도 (OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO) | ⤷ Sign Up |
Mexico | 2023003124 | COMPOSICIONES FARMACEUTICAS OFTALMICAS Y USOS QUE SE RELACIONAN A LAS MISMAS. (OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO.) | ⤷ Sign Up |
Russian Federation | 2019107585 | ОФТАЛЬМОЛОГИЧЕСКИЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ | ⤷ Sign Up |
Spain | 2934790 | ⤷ Sign Up | |
Israel | 264664 | ⤷ Sign Up | |
Japan | 2023105147 | 眼科用医薬組成物及びそれに関する使用 (OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES RELATING THERETO) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |